MedTrace Logo

Efficacy and Safety of Bromfenac Ophthalmic Solution

NCT00585975 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 568

Last updated 2013-02-15

Study results available
· View outcomes & findings →

Summary

This is a safety and efficacy study of bromfenac ophthalmic solution

Conditions

  • Cataract Surgery

Interventions

DRUG

bromfenac ophthalmic solution

sterile opthalmic solution

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Principal Investigators

  • Tim McNamara, PharmD · ISTA Pharmaceuticals, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2008-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00585975 on ClinicalTrials.gov